The authors report the case of a drug abuser treated successfully for fungal tricuspid endocarditis complicated by massive pulmonary embolism. Partial valvular replacement with a segment of a tricuspid homograft associated with disobliteration of a pulmonary artery was performed. Peroperative transoesophageal echocardiography showed satisfactory tricuspid valve function. The postoperative course was uneventful. After 5 months' follow-up, the patient was asymptomatic and in good general condition. Control echocardiography showed a stable operative result.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Partial replacement of the tricuspid valve using cryopreserved tricuspid homograft: 20-year outcomes.
Interdiscip Cardiovasc Thorac Surg
January 2025
Division of Cardiothoracic Surgery, Heart and Lung Institute, The Prince Charles Hospital, Brisbane, Australia.
Objectives: There is limited consensus on the optimal strategy for surgical treatment of severe tricuspid valve pathology. At our institution, we have implemented a unique technique of using a tricuspid homograft with its supporting apparatus for partial replacement of the native tricuspid valve. We now present the long-term outcomes of these patients.
View Article and Find Full Text PDFThe Year in Cardiothoracic Transplant Anesthesia: Selected Highlights From 2022 Part II: Cardiac Transplantation.
J Cardiothorac Vasc Anesth
October 2024
University of Pittsburgh, Pittsburgh, PA. Electronic address:
Article Synopsis
- The highlights cover research from 2022 divided into three sections: preoperative, intraoperative, and postoperative, focusing on advancements in heart transplantation.
- The preoperative section discusses candidate assessment, donor optimization, and factors like cannabis use and comorbidities that impact transplantation success.
- The intraoperative section emphasizes teamwork and surgical techniques while the postoperative section highlights managing complications like tricuspid regurgitation and exploring xenotransplantation options.
Choice of valve substitutes.
Indian J Thorac Cardiovasc Surg
May 2024
Department of Cardiothoracic and Vascular Surgery, All India Institute of Medical Sciences, CVTS Office 7th Floor, Cardiothoracic and Neurosciences Centre, Ansari Nagar, New Delhi, 110029 India.
Infective endocarditis often necessitates surgical intervention, and the choice of valve substitute remains a topic of controversy and highly debatable due to the wide range of available options and recent technical advancements. This manuscript reviews the different valve substitutes in the context of infective endocarditis, including mechanical and bioprosthetic valves, homografts, xenografts, and tissue-engineered valves. The patient's age, sex, demographic location, intellectual quotient, comorbidities, available options, and the experience of the surgeon should all be taken into consideration while choosing the best valve substitute for that individual.
View Article and Find Full Text PDFConcomitant large atrial septal defect closure, biatrial cryoablation and tricuspid valve replacement with mitral homograft.
Asian Cardiovasc Thorac Ann
May 2024
Department of Cardiac Surgery, State Budgetary Healthcare Institution "Chelyabinsk Regional Clinical Hospital," Chelyabinsk, Russian Federation.
The concomitant large atrial septal defect closure, endocardial biatrial cryoablation and tricuspid valve replacement with mitral homograft in a patient with adult congenital heart disease is presented. Because of the severely dilated right ventricle and leaflet tenting, tricuspid valve replacement was considered. The patient refused both mechanical and stented biological prosthesis due to personal beliefs, therefore, the alternative valve substitute was proposed.
View Article and Find Full Text PDFTricuspid valve repair for infective endocarditis.
Interdiscip Cardiovasc Thorac Surg
May 2024
Department of Cardiothoracic and Vascular Surgery, Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Objectives: The progressive increase in the use of implantable electronic devices, vascular access for dialysis and the increased life expectancy of patients with congenital heart diseases has led in recent years to a considerable number of right-side infective endocarditis, especially of the tricuspid valve (TV). Although current guidelines recommend TV repair for native tricuspid valve endocarditis (TVE), the percentage of valve replacements remains very high in numerous studies. The aim of our study is to analyse our experience in the treatment of TVE with a reparative approach.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!